Frontiers in Pharmacology · 2020 · 23 citations · 37 references
MedicineOncologyPharmacologyImmunoregulationInflammationTumor MicroenvironmentCancer ImmunotherapyCytokines In Tumor ImmunityHepatocellular CarcinomaLiver DiseaseMyeloid-derived Suppressor CellsTumor Microenvironment ModulationAngiogenesis ImpairmentHepatocellular Carcinoma TreatmentImmunosuppressive FunctionImmunosuppressive MicroenvironmentLiver Tumor MicroenvironmentMyeloid-derived Suppressor Cell ModulationTraditional Chinese MedicineTumor Microenvironment Regulation
Gehua Jiecheng Decoction (GHJCD), a famous traditional Chinese medicine, has been used in the prevention and treatment of precancerous lesion of liver cancer, but its active mechanism has not been reported. This study aimed to evaluate the therapeutic effect of GHJCD on diethylnitrosamine (DEN)-induced hepatocellular carcinoma (HCC) in mice and the mechanism of this effect. We found that GHJCD effectively inhibited the occurrence of liver cancer and reduced the tumor area. The ratio of regulatory cells (Tregs), tumor-associated macrophages (TAMs), and myeloid-derived suppressor cells (MDSCs) in HCC microenvironment was down-regulated, whereas that of CD8 T and effective CD8 T cells was up-regulated. In addition, the expression levels of inflammatory factors IL-6, IL-10, TNF-α, and CCL-2 in the liver were inhibited, whereas those of the angiogenesis related molecules CD31 and VEGF were decreased. Moreover, WNT1, β-catenin, NF-kB, p-MAPK, p-AKT, and p-SRC content in the liver decreased, whereas APC content increased. These results suggested that GHJCD exerted a good inhibitory effect on liver cancer induced by DEN and thus may have a multi-target effect; GHJCD not only antagonized the immunosuppressive effect of the microenvironment of liver cancer but also exerted strong anti-inflammatory and antiangiogenesis effects.
37
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2018 · 17K citations · Full text
TNF signaling drives myeloid-derived suppressor cell accumulation
Xueqiang Zhao, Lijie Rong, Xiaopu Zhao et al. · Journal of Clinical Investigation · 2012 · 373 citations · Full text
Medicine, Immunology, Oncology +17
Sith Sathornsumetee, Yiting Cao, Jennifer Marcello et al. · Journal of Clinical Oncology · 2008 · 262 citations · Full text
Medicine, Oncology, Pharmacology +17